China Resources Pharmaceutical Group Limited (SEHK: 3320)
Health Care · Pharmaceuticals · HK
HK$4.81
-0.72% today · -7.9% 1Y
China Resources Pharmaceutical Group Limited (SEHK: 3320) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.85B and employs 85,600 people.
Over the last twelve months the share price has lost 7.9%, trading between 4.22 and 6.53.
Tweenvest scores China Resources Pharmaceutical Group Limited across four factors: quality 81/100, value 74/100, growth 58/100, dividend 87/100. Its strongest factor is dividend.
3320 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.85B
- Revenue (TTM)
- $38.54B
- P/E
- 6.72
- EPS
- 0.64
- Dividend yield
- 4.70%
- Beta (5Y)
- -0.39
- 52-week high
- HK$6.53
- 52-week low
- HK$4.22
- Avg volume (3M)
- —
- Shares outstanding
- 6.28B
- Employees
- 85,600
- Next earnings
- —
About China Resources Pharmaceutical Group Limited
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular diseases, alimentary tract, endocrine diseases, respiratory diseases, orthopedics, nephrology, rheumatology and immunology, medical nutrition, pediatrics, genitourinary system, dermatological diseases, blood products, therapeutic infusions, antitumor drugs, medicine for cough and cold, anti-infection drugs, and psychoneurosis. It also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical/medical device manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company is involved in property holding activities, as well as operates retail pharmacies under the Teck Soon Hong brands. It distributes its products under the 999, Dong-E-E-Jiao, Double Crane, Zizhu, Jiangzhong, Boya, and Kun Zhong Yao to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.
- ISIN
- HK0000311099
- Founded
- 2007
- Listed since
- Oct 28, 2016
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.